These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23812757)

  • 21. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia.
    Tillet E; Bailly S
    Front Genet; 2014; 5():456. PubMed ID: 25620979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
    Upton PD; Davies RJ; Trembath RC; Morrell NW
    J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
    Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BMP9 and BMP10 are necessary for proper closure of the ductus arteriosus.
    Levet S; Ouarné M; Ciais D; Coutton C; Subileau M; Mallet C; Ricard N; Bidart M; Debillon T; Faravelli F; Rooryck C; Feige JJ; Tillet E; Bailly S
    Proc Natl Acad Sci U S A; 2015 Jun; 112(25):E3207-15. PubMed ID: 26056270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood flow regulates acvrl1 transcription via ligand-dependent Alk1 activity.
    Anzell AR; Kunz AB; Donovan JP; Tran TG; Lu X; Young S; Roman BL
    Angiogenesis; 2024 Aug; 27(3):501-522. PubMed ID: 38727966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10.
    Ruiz S; Zhao H; Chandakkar P; Chatterjee PK; Papoin J; Blanc L; Metz CN; Campagne F; Marambaud P
    Sci Rep; 2016 Nov; 5():37366. PubMed ID: 27874028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth.
    Mitchell D; Pobre EG; Mulivor AW; Grinberg AV; Castonguay R; Monnell TE; Solban N; Ucran JA; Pearsall RS; Underwood KW; Seehra J; Kumar R
    Mol Cancer Ther; 2010 Feb; 9(2):379-88. PubMed ID: 20124460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of
    Hodgson J; Swietlik EM; Salmon RM; Hadinnapola C; Nikolic I; Wharton J; Guo J; Liley J; Haimel M; Bleda M; Southgate L; Machado RD; Martin JM; Treacy CM; Yates K; Daugherty LC; Shamardina O; Whitehorn D; Holden S; Bogaard HJ; Church C; Coghlan G; Condliffe R; Corris PA; Danesino C; Eyries M; Gall H; Ghio S; Ghofrani HA; Gibbs JSR; Girerd B; Houweling AC; Howard L; Humbert M; Kiely DG; Kovacs G; Lawrie A; MacKenzie Ross RV; Moledina S; Montani D; Olschewski A; Olschewski H; Ouwehand WH; Peacock AJ; Pepke-Zaba J; Prokopenko I; Rhodes CJ; Scelsi L; Seeger W; Soubrier F; Suntharalingam J; Toshner MR; Trembath RC; Vonk Noordegraaf A; Wort SJ; Wilkins MR; Yu PB; Li W; Gräf S; Upton PD; Morrell NW
    Am J Respir Crit Care Med; 2020 Mar; 201(5):575-585. PubMed ID: 31661308
    [No Abstract]   [Full Text] [Related]  

  • 29. BMP9/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration.
    Ntumba K; Akla N; Oh SP; Eichmann A; Larrivée B
    Oncotarget; 2016 Aug; 7(35):55957-55969. PubMed ID: 27517154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.
    Luo J; Tang M; Huang J; He BC; Gao JL; Chen L; Zuo GW; Zhang W; Luo Q; Shi Q; Zhang BQ; Bi Y; Luo X; Jiang W; Su Y; Shen J; Kim SH; Huang E; Gao Y; Zhou JZ; Yang K; Luu HH; Pan X; Haydon RC; Deng ZL; He TC
    J Biol Chem; 2010 Sep; 285(38):29588-98. PubMed ID: 20628059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
    Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
    Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
    Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
    J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone morphogenetic protein-9 is a circulating vascular quiescence factor.
    David L; Mallet C; Keramidas M; Lamandé N; Gasc JM; Dupuis-Girod S; Plauchu H; Feige JJ; Bailly S
    Circ Res; 2008 Apr; 102(8):914-22. PubMed ID: 18309101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
    van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
    J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis.
    Desroches-Castan A; Tillet E; Ricard N; Ouarné M; Mallet C; Belmudes L; Couté Y; Boillot O; Scoazec JY; Bailly S; Feige JJ
    Hepatology; 2019 Oct; 70(4):1392-1408. PubMed ID: 30964206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone morphogenetic protein‑9 promotes the differentiation of mouse spleen macrophages into osteoclasts via the ALK1 receptor and ERK 1/2 pathways in vitro.
    Li H; Zhao D; Wang S; Ding J; Zhao L
    Mol Med Rep; 2016 Nov; 14(5):4545-4550. PubMed ID: 27748860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALK1 signaling is required for the homeostasis of Kupffer cells and prevention of bacterial infection.
    Zhao D; Yang F; Wang Y; Li S; Li Y; Hou F; Yang W; Liu D; Tao Y; Li Q; Wang J; He F; Tang L
    J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34874921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis.
    Owen NE; Alexander GJ; Sen S; Bunclark K; Polwarth G; Pepke-Zaba J; Davenport AP; Morrell NW; Upton PD
    EBioMedicine; 2020 Jun; 56():102794. PubMed ID: 32454407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
    Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
    J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Bmp10 acts through endothelial Alk1 to mediate flow-dependent arterial quiescence.
    Laux DW; Young S; Donovan JP; Mansfield CJ; Upton PD; Roman BL
    Development; 2013 Aug; 140(16):3403-12. PubMed ID: 23863480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.